| FLI-1 mediates tumor suppressor function via Klotho signaling in regulating CRC | None |
| c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. | breast, |
| Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing s sarcoma. | sarcoma, |
| dysregulated expression of spi-1/pu.1 and fli-1 oncogenes is involved in murine erythroleukemia cell differentiation arrest | leukemia, |
| Ewing s sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. | sarcoma, |
| Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. | sarcoma, |
| A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing s sarcoma. | sarcoma, |
| FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing s sarcoma cells. | sarcoma, |
| a novel oncogenic mechanism in Ewing sarcoma, involving post-transcriptional derepression of IGF signaling by the EWS/Fli1 fusion oncoprotein via miRs | sarcoma, |
| Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-beta abolishes ewing sarcoma growth. | sarcoma, |
| We found that transcriptional activation of PRKCB was directly regulated by the chimeric fusion oncogene EWSR1-FLI1 that drivesewing sarcoma growth. | sarcoma, |
| Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia. | leukemia, |
| Fli1 functioned as an oncogene in HCC carcinogenesis and it exerted its promoting metastatic effect primarily by modulating the matrix metalloproteinase (MMP)2 signaling pathway. | liver, |
| In Ewing Sarcoma cells, EGR1 upregulated IGF1R expression and enhanced the expression of the oncogenic fusion protein EWS-FLI1 | sarcoma, |
| The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing s sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. | sarcoma,leukemia, |
| An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. | kidney, |
| Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. | leukemia, |
| An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1. | None |
| Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. | None |
| Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. | None |